Respuestas clínicas Cochrane
- How do provider‐ or system‐based interventions impact the uptake of influenza vaccination in people aged 60 or older?
- How do interventions aimed at increasing community demand impact the uptake of influenza vaccination in people aged 60 or older?
- In healthy adults, what are the benefits and harms of vaccines for preventing influenza?
- In healthy children, what are the benefits and harms of vaccines for preventing influenza?
- Does randomized controlled trial evidence support the use of vaccines to prevent influenza in the elderly?
- What are the benefits and harms of neuraminidase inhibitors for the treatment of influenza in otherwise healthy adults?
- In children with clinically or serologically confirmed influenza A, do amantadine and rimantadine improve outcomes?
- If there is an outbreak of influenza A in the community, do amantadine and rimantadine given prophylactically prevent the development of influenza in children?
- If there is an outbreak of influenza A in the community, do amantadine and rimantadine given prophylactically prevent the development of influenza in the elderly?
- What are the benefits and harms of neuraminidase inhibitors for the prevention of influenza in adults?
Niveles de evidencia
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad